Clinical trial
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
NCT00004579 · Walter Reed Army Institute of Research (WRAIR), U.S. Fed · Completed
Key facts
| NCT number | NCT00004579 |
|---|---|
| Title | A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection |
| Official title | A Phase I, Dose-Ranging Trial of the Pasteur Merieux Connaught (PMC) Oligomeric HIV-1 gp160MN/LAI-2 Vaccine Alone or Primed With Live Recombinant ALVAC-HIV (vCP205) in HIV Seronegative Adults |
| Lead sponsor | Walter Reed Army Institute of Research (WRAIR), U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, HIV Seronegativity |
| Intervention type | Biological |
| Interventions | gp160 MN/LAI-2, ALVAC-HIV MN120TMG (vCP205) |
| Start date | Apr 1, 1998 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: